Lindbrook Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Lindbrook Capital’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-164	Closed	-$4.43K	–	2930
2024 Q2	$4.43K	Hold	164	–	–	﹤0.01%	2053
2024 Q1	$3K	Hold	164	–	–	﹤0.01%	2098
2023 Q4	$2.01K	Buy	164 +13	+9%	+$122	﹤0.01%	2256
2023 Q3	$2.26K	Buy	+151	New	+$3.14K	﹤0.01%	2077
2023 Q2	–	Sell	-25	Closed	-$978	–	2877
2023 Q1	$978	Sell	25 -21	-46%	-$1.03K	﹤0.01%	2457
2022 Q4	$2.43K	Buy	46 +5	+12%	+$244	﹤0.01%	2158
2022 Q3	$2K	Buy	41 +16	+64%	+$688	﹤0.01%	2182
2022 Q2	$1K	Buy	+25	New	+$908	﹤0.01%	2425

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's SILK Position: Q3 2024 in Review

Lindbrook Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 164 shares — an estimated $4.43K sold.

Lindbrook Capital first reported a position in SILK in Q2 2022 and held it in 8 quarters. The position peaked at $4.43K in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

Lindbrook Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Lindbrook Capital sold 164 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $4.43K.
Lindbrook Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Lindbrook Capital's Silk Road Medical, Inc. Common Stock position peaked at $4.43K in Q2 2024.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Lindbrook Capital's 13F filing for Q3 2024, filed 1 Nov 2024.